(2R,3R,4R,5R)-2,5-bis(3-bromobenzyloxy)-3,4-dihydroxy-N1-((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)-N6-((R)-4-methoxy-3-oxo-2,3-dihydro-1H-inden-1-yl)hexanediamide

ID: ALA5287378

Max Phase: Preclinical

Molecular Formula: C39H38Br2N2O9

Molecular Weight: 838.55

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc2c1C(=O)C[C@H]2NC(=O)[C@H](OCc1cccc(Br)c1)[C@H](O)[C@@H](O)[C@@H](OCc1cccc(Br)c1)C(=O)N[C@H]1c2ccccc2C[C@H]1O

Standard InChI:  InChI=1S/C39H38Br2N2O9/c1-50-31-14-6-13-27-28(18-29(44)32(27)31)42-38(48)36(51-19-21-7-4-10-24(40)15-21)34(46)35(47)37(52-20-22-8-5-11-25(41)16-22)39(49)43-33-26-12-3-2-9-23(26)17-30(33)45/h2-16,28,30,33-37,45-47H,17-20H2,1H3,(H,42,48)(H,43,49)/t28-,30-,33+,34-,35-,36-,37-/m1/s1

Standard InChI Key:  OBYWZOSJDGNULF-UMJIWMCASA-N

Molfile:  

 
     RDKit          2D

 52 57  0  0  0  0  0  0  0  0999 V2000
   12.9547  -17.2839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5639  -17.6274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3056  -16.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5021  -16.6739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0123  -18.2394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2048  -18.0701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7941  -18.7856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3479  -19.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1007  -19.0596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9772  -18.8737    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8134  -19.4686    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5240  -19.0558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2367  -19.4647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5218  -18.2340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2389  -20.2864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9472  -19.0519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6600  -19.4608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9450  -18.2302    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6622  -20.2826    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3704  -19.0481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5283  -20.6993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5305  -21.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8181  -21.9307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8199  -22.7517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5332  -23.1614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2460  -22.7442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2407  -21.9246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1091  -23.1641    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   19.0832  -19.4571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3683  -18.2263    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0788  -17.8135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0765  -16.9918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7875  -16.5851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7857  -15.7641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0724  -15.3544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3595  -15.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3649  -16.5911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4964  -15.3516    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   19.0854  -20.2788    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7938  -19.0442    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.5065  -19.4532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8121  -19.7246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2606  -19.1155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4031  -20.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6026  -20.2692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0587  -20.8776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3140  -21.6544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1183  -21.8194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6589  -21.2097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4294  -18.3114    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1566  -17.1102    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6053  -17.7197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0
  5  2  2  0
  2  3  1  0
  3  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  7 10  2  0
  9 11  1  6
 11 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  1
 13 16  1  0
 16 17  1  0
 16 18  1  6
 17 19  1  6
 17 20  1  0
 15 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 24 28  1  0
 20 29  1  0
 20 30  1  1
 30 31  1  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 32  1  0
 34 38  1  0
 29 39  2  0
 29 40  1  0
 41 40  1  6
 41 45  1  0
 44 42  1  0
 42 43  1  0
 43 41  1  0
 44 45  2  0
 45 46  1  0
 46 47  2  0
 47 48  1  0
 48 49  2  0
 49 44  1  0
 43 50  1  6
 51 52  1  0
  1 51  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287378

    ---

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 protease (9113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 838.55Molecular Weight (Monoisotopic): 836.0944AlogP: 4.63#Rotatable Bonds: 14
Polar Surface Area: 163.65Molecular Species: NEUTRALHBA: 9HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.84CX Basic pKa: CX LogP: 4.33CX LogD: 4.33
Aromatic Rings: 4Heavy Atoms: 52QED Weighted: 0.12Np Likeness Score: 0.23

References

1. Ghosh AK, Osswald HL, Prato G..  (2016)  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.,  59  (11): [PMID:26799988] [10.1021/acs.jmedchem.5b01697]

Source